140 related articles for article (PubMed ID: 21352075)
1. Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital.
Wu JJ; Wang LR; Liu YF; Chen HM; Yan JJ
Microb Drug Resist; 2011 Jun; 17(2):259-66. PubMed ID: 21352075
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
[TBL] [Abstract][Full Text] [Related]
3. Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
Lee NY; Wu JJ; Lin SH; Ko WC; Tsai LH; Yan JJ
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1941-50. PubMed ID: 22249422
[TBL] [Abstract][Full Text] [Related]
4. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
[TBL] [Abstract][Full Text] [Related]
5. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
Wu JJ; Ko WC; Wu HM; Yan JJ
J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
[TBL] [Abstract][Full Text] [Related]
7. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan.
Yan JJ; Ko WC; Wu HM; Tsai SH; Chuang CL; Wu JJ
J Clin Microbiol; 2004 Nov; 42(11):5337-40. PubMed ID: 15528737
[TBL] [Abstract][Full Text] [Related]
8. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
[TBL] [Abstract][Full Text] [Related]
10. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
Cuzon G; Naas T; Guibert M; Nordmann P
Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
[TBL] [Abstract][Full Text] [Related]
11. Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
Leavitt A; Chmelnitsky I; Colodner R; Ofek I; Carmeli Y; Navon-Venezia S
J Clin Microbiol; 2009 Apr; 47(4):969-74. PubMed ID: 19213695
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
13. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
Findlay J; Hamouda A; Dancer SJ; Amyes SG
Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
[TBL] [Abstract][Full Text] [Related]
14. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia.
Bedenić B; Schmidt H; Herold S; Monaco M; Plecko V; Kalenić S; Katíc S; Skrlin-Subić J
J Chemother; 2005 Aug; 17(4):367-75. PubMed ID: 16167514
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan.
Yan JJ; Ko WC; Tsai SH; Wu HM; Wu JJ
J Clin Microbiol; 2001 Dec; 39(12):4433-9. PubMed ID: 11724857
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic characterization of β-lactam resistance in Klebsiella pneumoniae isolated from swine.
Zou LK; Wang HN; Zeng B; Zhang AY; Li JN; Li XT; Tian GB; Wei K; Zhou YS; Xu CW; Yang ZR
Vet Microbiol; 2011 Apr; 149(1-2):139-46. PubMed ID: 21035968
[TBL] [Abstract][Full Text] [Related]
18. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
19. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
20. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
